City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Vincent Chung, MD  
Search results:  7  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-7 Trials Jump to page:

COH Protocol Number: 13331 ClinicalTrials.gov Number: NCT01907802

Principal Investigator: Vincent Chung, MD
Sponsor: NCI Approved External Peer Review

Title:  PHI-73, NCI # 9343: A Phase 1 and Pharmacokinetic Study of Dabrafenib (GSK2118436B) in Patients with BRAF V600X Mutations and Renal or Hepatic Dysfunction

COH Protocol Number: 12294 ClinicalTrials.gov Number: NCT01658943

Principal Investigator: Vincent Chung, MD
Sponsor: Cooperative Group

Title:  SWOG S1115: Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) vs mFOLFOX in Patients with Metastatic Pancreatic Cancer After Prior Chemotherapy

COH Protocol Number: 12293 ClinicalTrials.gov Number: NCT01837667

Principal Investigator: Vincent Chung, MD
Sponsor: Industrial

Title:  A Phase I Study of Intravenous LB-100 for Injection as a Single Agent and in Combination with Docetaxel in the Treatment of Patients with Advanced Solid Tumors

COH Protocol Number: 12217 ClinicalTrials.gov Number: NCT01638533

Principal Investigator: Vincent Chung, MD
Sponsor: NCI Approved External Peer Review

Title:  PHI-72, NCI #9008: A Phase 1 and Pharmacokinetic Single Agent Study of Romidepsin in Patients with, Lymphomas, Chronic Lymphocytic Leukemia and Select Solid Tumors and Varying Degrees of Liver Dysfunction

COH Protocol Number: 12115 ClinicalTrials.gov Number: NCT01534598

Principal Investigator: Vincent Chung, MD
Sponsor: NCI Approved External Peer Review

Title:  PHI-70, NCI #9127: Phase I Trial of Oral 5-Fluoro-2'-Deoxycytidine with Oral Tetrahydrouridine in Patients with Advanced Solid Tumors

COH Protocol Number: 10226 ClinicalTrials.gov Number: NCT01273155

Principal Investigator: Vincent Chung, MD
Sponsor: NCI Approved External Peer Review

Title:  PHI-66 NCI#8846- Phase I Pharmacokinetic Study of Belinostat for Solid Tumors and Lymphomas in Patients with Varying Degrees of Hepatic Dysfunction

COH Protocol Number: 10220 ClinicalTrials.gov Number: NCT01366144

Principal Investigator: Vincent Chung, MD
Sponsor: NCI Approved External Peer Review

Title:  PHI-65, NCI #8808: An Early Phase I Study of ABT-888 in Combination with Carboplatin and Paclitaxel in Patients with Hepatic Renal Dysfunction and Solid Tumors

 
Results per page: 25 50 100 All 1-7 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.